Genexine Balance Sheet Health
Financial Health criteria checks 4/6
Genexine has a total shareholder equity of ₩288.1B and total debt of ₩68.5B, which brings its debt-to-equity ratio to 23.8%. Its total assets and total liabilities are ₩365.4B and ₩77.3B respectively.
Key information
23.8%
Debt to equity ratio
₩68.53b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩52.50b |
| Equity | ₩288.07b |
| Total liabilities | ₩77.32b |
| Total assets | ₩365.39b |
Financial Position Analysis
Short Term Liabilities: A095700's short term assets (₩66.7B) exceed its short term liabilities (₩51.8B).
Long Term Liabilities: A095700's short term assets (₩66.7B) exceed its long term liabilities (₩25.5B).
Debt to Equity History and Analysis
Debt Level: A095700's net debt to equity ratio (5.6%) is considered satisfactory.
Reducing Debt: A095700's debt to equity ratio has increased from 13.6% to 23.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A095700 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A095700 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 5.7% each year